# Lexicon Pharmaceuticals, Inc. (LXRX) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$49M |
| 2024 | -$197M |
| 2023 | -$172M |
| 2022 | -$101M |
| 2021 | -$87M |
| 2020 | -$48M |
| 2019 | $141M |
| 2018 | -$103M |
| 2017 | -$131M |
| 2016 | -$127M |
| 2015 | $1M |
| 2014 | -$100M |
| 2013 | -$102M |
| 2012 | -$108M |
| 2011 | -$114M |
| 2010 | -$96M |
| 2009 | -$90M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$996,000 |
| 2025-09-30 | -$12M |
| 2025-06-30 | $4M |
| 2025-03-31 | -$26M |
| 2024-09-30 | -$64M |
| 2024-06-30 | -$55M |
| 2024-03-31 | -$45M |
| 2023-09-30 | -$50M |
| 2023-06-30 | -$44M |
| 2023-03-31 | -$31M |
| 2022-09-30 | -$23M |
| 2022-06-30 | -$24M |
| 2021-09-30 | -$23M |
| 2021-06-30 | -$18M |
| 2021-03-31 | -$21M |
| 2020-09-30 | $87M |
| 2020-06-30 | -$65M |
| 2020-03-31 | -$62M |
| 2019-09-30 | $225M |
| 2019-06-30 | -$19M |
| 2019-03-31 | -$17M |
| 2018-09-30 | -$23M |
| 2018-06-30 | -$30M |
| 2018-03-31 | -$38M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/LXRX/operating-income)